On the filings, Gilead (GILD) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it HOLD.
Fair-value HIV cash machine: Biktarvy moat extended to 2036 and Yeztugo launching, but flat sales and oncology misses cap upside.
Balance-sheet-strong turnaround with revenue finally stabilizing, but falling earnings and a full its multiple leave no margin of safety.
| Metric | GILD | BIIB |
|---|---|---|
| Fundamentals score | 85 | 66 |
| Revenue growth (YoY) | +2.4% | +2.2% |
| Net income growth (YoY) | +1672.9% | -20.8% |
| Net margin | 28.9% | 13.1% |
| Return on equity | 37.5% | 7.1% |
| ROIC (est.) | 16.6% | 9.1% |
| Liabilities / Equity | — | 0.61 |
| Piotroski F-score | 7 / 9 | 5 / 9 |
Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 19, 2026, 2:16 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 2, 2026, 9:51 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.